Original articles

Distribution of Traditional Chinese Medicine syndromes in diabetic kidney disease chronic kidney disease 1-5: a correlation study

  • Shuang LI ,
  • Shuwei DUAN ,
  • Zheyi DONG ,
  • Yilun QU ,
  • Yayong LUO ,
  • Jianghua KE ,
  • Conghui WANG ,
  • Yangzhi PENG ,
  • Xuefeng ZHOU ,
  • Xiangmei CHEN
Expand
  • 1 Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China
    2 Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China; School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China
    3 Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China; Basic Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China

Received date: 2022-12-27

  Accepted date: 2023-05-25

  Online published: 2023-08-02

Supported by

Beijing Science and Technology Plan Project: Study on Multidimensional Precise Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetic Nephropathy(Z221100007422121);Beijing Science and Technology Plan Project: Correlation between Clinical Phenotype and Pathological Diagnosis of Type 2 Diabetic Nephropathy(D171100002817002);State Key Research and Development Program: Study on the Core Pathogenesis and Clinical Evolution of Damp-heat Symptom in Diabetic Nephropathy(2018YFC1704203);National Key R&D Program of China(2018YFC1704200);Natural Science Foundation of China: Mechanism of Organ Immune Injury and Basic Research of Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment(32141005)

Abstract

OBJECTIVE: To analyze the distribution of Traditional Chinese medicine (TCM) syndromes in patients with diabetic kidney disease (DKD) and its related factors.

METHODS: We enrolled 435 patients with DKD, who were not undergoing dialysis, admitted to the Department of Nephrology, First Medical Center, Chinese PLA General Hospital from April 2020 to August 2021. Analysis of their TCM syndromes and related factors was carried out.

RESULTS: The 435 patients included 109, 117, 86, and 123 chronic kidney disease (CKD) 1-2, CKD3, CKD4, and CKD5 cases, respectively. With the progression of CKD1-5, the proportion of Yin deficiency and dry heat syndrome, and that of Qi and Yin deficiency syndrome showed a downward trend, whereas the proportion of spleen-kidney Yang deficiency, blood deficiency, blood stasis, water stagnation, and phlegm turbidity syndromes showed an upward trend; the differences were statistically significant (P < 0.05). Multivariate logistic regression analysis showed that Yin deficiency and dry heat syndrome was positively correlated with hemoglobin [odds ratio (OR) = 1.022, P = 0.005], albumin (OR = 1.058, P = 0.006), and estimated glomerular filtration rate (eGFR) (OR = 1.020, P < 0.001) but negatively correlated with male sex (OR = 0.277, P = 0.004). Qi and Yin deficiency syndrome was positively correlated with albumin (OR = 1.056, P < 0.001) and eGFR (OR = 1.008, P = 0.022) but negatively correlated with age (OR = 0.977, P = 0.023). Liver-kidney Yin deficiency syndrome was positively correlated with age (OR = 1.028, P = 0.021) and glycosylated hemoglobin (OR = 1.223, P = 0.007) but negatively correlated with total cholesterol (OR = 0.792, P = 0.006). Spleen-kidney Yang deficiency syndrome was negatively correlated with hemoglobin (OR = 0.977, P < 0.001), albumin (OR = 0.891, P < 0.001), and eGFR (OR = 0.978, P < 0.001) but positively correlated with high density lipoprotein (OR = 3.376, P = 0.001).

CONCLUSION: With CKD1-5 progression, TCM syndromes changed from Yin deficiency and dry heat syndrome to syndrome of deficiency of both Qi and Yin, liver-kidney Yin, and spleen-kidney Yang deficiency syndromes. TCM syndromes were correlated with laboratory test results.

Cite this article

Shuang LI , Shuwei DUAN , Zheyi DONG , Yilun QU , Yayong LUO , Jianghua KE , Conghui WANG , Yangzhi PENG , Xuefeng ZHOU , Xiangmei CHEN . Distribution of Traditional Chinese Medicine syndromes in diabetic kidney disease chronic kidney disease 1-5: a correlation study[J]. Journal of Traditional Chinese Medicine, 2024 , 44(3) : 572 -580 . DOI: 10.19852/j.cnki.jtcm.20230802.007

References

1. Saeedi P, Petersohn I, Salpea P, et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th ed. Diabetes Res Clin Pract 2019; 157: 107843.
2. Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition). Zhong Guo Shi Yong Nei Ke Za Zhi 2018; 38: 292-344.
3. Doshi SM, Friedman AN. Diagnosis and management of type 2 diabetic kidney disease. Clin J Am Soc Nephrol 2017; 12: 1366-73.
4. Tripathi YB, Yadav D. Diabetic nephropathy: causes and managements. Recent Pat Endocr Metab Immune Drug Discov 2013; 7: 57-64.
5. Lytvyn Y, Bjornstad P, van Raalte DH, Heerspink HL, Cherney DZI. The new biology of diabetic kidney disease-mechanisms and therapeutic implications. Endocr Rev 2020; 41: 202-31.
6. Liao T, Zhao K, Huang Q, et al. A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease. Medicine (Baltimore) 2020; 99: e21137.
7. Wang X, Yang H, Zhang L, et al. Network pharmacology-based prediction of mechanism of Shenzhuo formula for application to DKD. Evid Based Complement Alternat Med 2021; 17: 6623010.
8. Zhang L, Yang L, Shergis J, et al. Chinese herbal medicine for diabetic kidney disease: a systematic review and Meta-analysis of randomised placebo-controlled trials. BMJ Open 2019; 9: e025653.
9. Piao Y, Yin D. Mechanism underlying treatment of diabetic kidney disease using Traditional Chinese Medicine based on theory of Yin and Yang balance. J Tradit Chin Med 2018; 38: 797-802.
10. Cao X, Wei R, Zhou J, et al. Wenshen Jianpi recipe, a blended Traditional Chinese Medicine, ameliorates proteinuria and renal injury in a rat model of diabetic nephropathy. BMC Complement Altern Med 2019; 19: 193.
11. Dong Z, Sun Y, Wei G, Li S, Zhao Z. A nucleoside/nucleobase-rich extract from cordyceps sinensis inhibits the epithelial-mesenchymal transition and protects against renal fibrosis in diabetic nephropathy. Molecules 2019; 24: 4119.
12. Stevens PE, Levin A. Kidney disease: improving global outcomes chronic kidney disease guideline development work group members. evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013; 158: 825-30.
13. Yang NZ, Liu XS. Diabetic nephropathy diagnosis, syndrome differentiation and curative effect evaluation standard (trial scheme). Shanghai Zhong Yi Yao Za Zhi 2007; 41: 7-8.
14. Gao YB, Liu TH, Li P. Guidelines of TCM prevention and treatment of diabetic nephropathy. Zhong Guo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu 2011; 9: 151-3.
15. Lyu RH, Zhang JR, Gao YB. Criteria for TCM staging, syndrome differentiation and curative effect evaluation of diabetes mellitus (diabetes mellitus). Zhong Guo Yi Yao Xue Bao 1993; 8: 54-6.
16. Zheng XY. Guiding principles for clinical research of new Traditional Chinese Medicines. Beijing: China Medical Science and Technology Press, 2002: 233-7.
17. Han XJ, Lian ZH, Liu MY, et al. Applicability assessment and revision suggestions on guide for diabetes prevention and control of Traditional Chinese Medicine. Zhong Hua Zhong Yi Yao Za Zhi 2016; 31: 169-71.
18. Zheng SS, Xu YQ, Chen ZJ, Ji L, Mu X. Distribution of TCM syndromes of diabetic nephropathy based on literature analysis. Zhong Guo Zhong Yi Yao Ke Ji 2019; 26: 478-80.
19. Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008; 51: 373-84.
20. Shao XX, Zhang P, Yao X, Zhang L, Chen JH. Demographic and primary disease changes of new dialysis patients with end-stage renal disease in Zhejiang province from 2008 to 2013. Zhong Hua Shen Zang Bing Za Zhi 2016; 32: 106-9.
21. Zhou Y, Wen Y, Pu L, Wu SK, Li GS. Epidemiological survey of new hemodialysis patients in Sichuan province (2011-2016). Shen Zang Bing Yu Tou Xi Shen Yi Zhi Za Zhi 2018; 27: 311-4, 395.
22. Chinese Medical Association. Guidelines for clinical diagnosis and treatment of renal disease. Beijing: People 's Health Publishing House, 2011: 109-14.
23. Boyko EJ, Seelig AD, Ahroni JH. Limb- and person-level risk factors for lower-limb amputation in the prospective seattle diabetic foot study. Diabetes Care 2018; 41: 891-8.
24. Ito K, Yokota S, Watanabe M, et al. Anemia in diabetic patients reflects severe tubulointerstitial injury and aids in clinically predicting a diagnosis of diabetic nephropathy. Internal Med 2021; 60: 1349-57.
25. Williams ME. Diabetic nephropathy: the proteinuria hypothesis. Am J Nephrol 2005; 25: 77-94.
26. Yang LP, Li P, Du JH, et al. Canonical correlation analysis of TCM syndrome and laboratory parameters in 350 patients with diabetic nephropathy. Zhong Hua Zhong Yi Yao Za Zhi 2010; 25: 686-9.
Outlines

/